Eli Lilly and Co

Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates.…

We don’t want to get caught too deep in the weeds. Don’t overcomplicate things. It will only lead…

Eli Lilly on Thursday reported third-quarter earnings and revenue that blew past estimates and hiked its full-year sales…

Screens display the Fed rate announcement as traders work on the floor of the NYSE in New York…

With open enrollment season in swing, many employees may notice something conspicuously missing from their benefits menu —…

Jim Cramer said Monday that even tech-focused people think the world of Eli Lilly stock, with one predicting…

Earnings season is in full swing, and more tech giants are slated to report in the new week…

You focus too much on one single aspect of this market — one single bad aspect — and…

Novo on Tuesday said its next-generation obesity drug, CagriSema, showed 25% weight loss on average among adult women…

The sinking AI trade and hotter-than-expected inflation data rattled last week’s stock market. But solid bank earnings and…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

CNBC’s Jim Cramer said Thursday that this week’s turbulence in artificial intelligence stocks is delivering a painful reminder…

Novo raises full-year outlook as Wegovy pill sales impress